Dengue Vaccine Market Technology Trends
Technology innovation shapes the Dengue Vaccine Market landscape across multiple development fronts. Live attenuated vaccines remain the dominant technology, generating $0.9 billion in 2024 and projected to reach $2.5 billion by 2032. These vaccines elicit strong immune responses and provide durable protection against multiple dengue serotypes.
Inactivated vaccines offer enhanced safety...
0 Condivisioni
57 Visualizzazioni